Tests | % Agreement with nested PCR (Kappa) | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|
(95% CI) | (95% CI) | (95% CI) | (95% CI) | ||
Before treatment | |||||
HRP-2-RDTs | 81% | 84 | 78 | 79 | 83 |
(0.63) | (75.3, 90.6) | (68.6, 85.7) | (69.7, 86.5) | (74.2, 89.8) | |
Microscopy | 85% | 72 | 98 | 98 | 78 |
(0.70) | (62.1, 80.5) | (93.0, 99.8) | (93.0, 99.8) | (68.6, 85.7) | |
LAMP | 99% | 100 | 98 | 98 | 100 |
(0.98) | (96.4, 100) | (93.0, 99.8) | (93.0, 99.8) | (96.4, 100) | |
On day 7 after first-line treatment | |||||
HRP-2-RDTs | 61% | 58 | 61 | 21 | 89 |
(0.11) | (47.7, 67.8) | (50.7, 70.6) | (13.5, 30.3) | (81.2, 94.4) | |
Microscopy | 94% | 58 | 100 | 100 | 93 |
(0.70) | (47.7, 67.8) | (96.4, 100) | (96.4, 100) | (86.1, 97.1) | |
LAMP | 99% | 92 | 100 | 100 | 99 |
(0.95) | (84.8, 96.5) | (96.4, 100) | (96.4, 100) | (94.6, 99.9) |